Rua Diagnostics logo
Rua Diagnostics logo

Rua Diagnostics

ruadiagnostics.com
ruadiagnostics.com • HQ: Westbury, United States • Venture - Series Unknown 2026 • 11-50 employees • Founded 2023 • Startup • New
HQ: Westbury, United States • Venture - Series Unknown 2026 • 11-50 employees • Founded 2023 • Startup • New
Actively hiring
Laboratory Equipment
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3.7M
1 round on record
Latest round
$3.7M
Venture round · May 2026 · 5 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 13 Raised a round Venture round $3.7M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2026 $3.7M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Rua Diagnostics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jonathan OrrExecutive Officer, DirectorSEC Form D
Jillian LevovitzExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs CellChorus
Plug and Play
backs Signaiture
Oxford Science Enterprises
backs Refeyn
Global Brain
backs ThinkCyte
High-Tech Gründerfonds
backs Irubis
RA Capital Management
backs Element Biosciences
Similar startupsby what they do, their industry and backers
Signaiture
Top of page Improving How Drugs Go To Market OUR MISSION Speed & Accuracy SignAIture enhances speed and accuracy in pharmaceutical quality…
Exokeryx
Meet EXOKĒRYX™ Powering EV research to realize earlier disease detection. We're speeding up the fight against cancer and other diseases by…
ABio-XFounded 2021
Join ABio-X: life sciences incubator driving novel drug discovery and company formation to address large, daunting diseases.
CellChorus
CellChorus conducts dynamic single-cell analysis at scale. Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) uses visual AI to…
ThinkCyteSeries C $32M · 2 yr ago • 201-500 employees
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support…
Element BiosciencesSeries D $277M · 2 yr ago • 201-500 employees • 16 roles
Scale without the premium. Introducing VITARI™ Who We Are Our Mission & Vision At Element Biosciences, our mission is to empower the…

Overview

Top of page The Potential of Breath Analysis Reimagine POC Diagnostics. Volatile Organic Compounds in the Breath Many disease states cause detectable changes in Volatile Organic Compounds (VOCs) which present in the lungs, as a result of disease-driven alterations in metabolic processes.

People

Jonathan Orr
Executive Officer, Director
SEC Form D
Jillian Levovitz
Executive Officer
SEC Form D
Peter Michalos
Director
SEC Form D
David Goone
Director
SEC Form D
Kenneth Orr
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Westbury United States
HQ
10-50 est. staff

Financials

Total raised
$3.7M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $3.7M Details